- Powder for Oral Suspension 40 mg/5 mL when reconstituted
- Gelcaps 10 mg
Pepcid AC EZ Chews
- Tablets, chewable 20 mg
Pepcid RPD
- Tablets 20 mg
- Tablets 40 mg
Apo-Famotidine (Canada)
Pharmacology Metabolism Special Populations Indications and Usage Dosage and AdministrationAdults Symptoms of GERD
PO 20 mg twice daily for up to 6 wk.
Esophagitis, including erosions and ulcerations
20 or 40 mg twice daily for up to 12 wk.
Children (younger than 3 mo of age)
PO 0.5 mg/kg once daily for up to 8 wk.
Children (3 mo to younger than 1 yr of age)
PO 0.5 mg/kg twice daily for up to 8 wk.
Children (1 to 16 yr of age)
PO 1 mg/kg/day divided twice daily (max, 40 mg twice daily).
Pathologic Hypersecretory Conditions
Adults
PO Start at 20 mg every 6 h, adjust to individual patient needs and continue as long as clinically indicated, doses up to 160 mg every 6 h have been used.
Moderately or Severely Impaired Renal Function (CrCl less than 50 mL/min)
May need to reduce dose 50%, or increase dosing interval to 36 to 46 h.
For Hospitalized Patients with Pathologic Hypersecretory Conditions, Intractable Ulcers, or Patients Unable to Take Orally
Parenteral use in GERD not established.
Adults and children 16 yr of age and older
IV 20 mg every 12 h.
Children (1 to 16 yr of age)
IV 0.25 mg/kg (injected over a period of no less than 2 min or as 15-min infusion) every 12 h (max 40 mg/day).
Heartburn, Acid Indigestion, Sour Stomach (OTC only)
Adults and Children 12 yr of age and older Acute
0 comments:
Post a Comment